Strategy Inc (STRD)

$HYSR SunHydrogen (HYSR) Products & Technologies
SunHydrogen Panel Technology
Their flagship product concept: a solar-powered panel that produces green hydrogen directly from sunlight and water. It’s designed to function like a traditional solar panel, but instead of generating elect

The "B" stands for biologics.

$KNDI Kandi Technologies (KNDI) — Full Product & Service Portfolio
Electric Vehicles
Kandi builds several categories of electric transportation, mostly compact and utility-focused.

Urban Electric Cars — small, affordable EVs designed for city driving

Neigh

$KNDI Kandi Technologies (KNDI) — Full Product & Service Portfolio
Electric Vehicles
Kandi builds several categories of electric transportation, mostly compact and utility-focused.

Urban Electric Cars — small, affordable EVs designed for city driving

Neigh

$BYND Beyond Meat (BYND) – Complete Product & Service Overview
🌱 Core Retail Products
Beyond Burger — flagship plant-based beef patty designed to replicate the flavor and texture of a traditional burger.

Beyond Beef — ground-beef alternative used for tacos, sauce

$BYND Beyond Meat (BYND) – Complete Product & Service Overview
🌱 Core Retail Products
Beyond Burger — flagship plant-based beef patty designed to replicate the flavor and texture of a traditional burger.

Beyond Beef — ground-beef alternative used for tacos, sauce

You're absolutely right. I don't think Pulte needs Senate confirmation for his interim position. Since I'm limited on the number of posts, forgive me for going off subject:

https://x.com/GuidoPerei/status/2062286733002334572?s=20

How is this scam still trading?

Rite has no mining equipment
Rite has no mining experience
Rite has no minable land

Rite scam waaaay past the right time..... it's actually harder to fool folks a third time using the same scam story of Skull Valley that

Q2 report is out.

Revenue down to just $101,529 which is the lowest reported in three years. And a loss of course.

Here's an interesting statement.

Management believes Primecare Supply represents a core growth engine for Global Technologies, Ltd., offerin

$2800 moved it 200%, imagine when we start seeing $280,000 days again. Easy 1000s% gains coming. Still zero dilution here. Some ignoring the fact that not a single share diluted.

https://investorshub.advfn.com/uimage/uploads/2026/6/3/vrrhwUntitled.png

------

Nice volume starting up

It's not going to take much to move us. Of course you will always have the 💩 heads who dump into the bids on every stock. With solid military defense contract news those guppies will lose all of their shares and they will be chasing when they realize that they are about to be left behind! I

A prophet is a prophet! (eom)

🔌 Plug Power: Full Product & Service Portfolio (Rewritten Clearly & Completely)
Hydrogen Fuel Cell Power Systems
GenDrive fuel cells — Drop-in replacements for lead-acid batteries used in electric forklifts across Class 1, 2, and 3 vehicles.

ProGen fuel cell engi

MY AI SAYS...

When someone writes thousands of words explaining why a company can't possibly do what it claims while the company continues doing more things that supposedly weren't possible...

At some point they're no longer documenting failure...

They’re

🔌 Plug Power: Full Product & Service Portfolio (Rewritten Clearly & Completely)
Hydrogen Fuel Cell Power Systems
GenDrive fuel cells — Drop-in replacements for lead-acid batteries used in electric forklifts across Class 1, 2, and 3 vehicles.

ProGen fuel cell engi

Yes, and let's hope about 600,000 of them have not bought yet.......that's a lot of possible investment for a small amount of free float. :-)

Shoe fits..

GolfnutBoston

Re: None

Friday, 01/30/2026 9:42:20 AM
Damn, back to the 2's. Where's the bottom?

one trade no biggie.........someone just gave his shares away.... sad for them

https://x.com/GuidoPerei/status/2062286733002334572?s=20

Well Edna, as an aging south paw, this might benefit you some day.

Jefferies - FDMT, EYPT (OCUL)

Just a housekeeping note. Both FDMT and EYPT presented, both with essentially the same well-polished presentations they have given recently with no notable updates or inferences.

OCUL is not doing this conference, yesterday they PR'd more

True. More like a biotech awaiting FDA approval.

Once it gets the nod and zooms based on regulatory approval, no one starts thinking about the gap.

Likely to assess the dubious P3 clinical trial REdesign after the trial was virtually completed. The final trial design was very different than the original trial design that was approved by the FDA and MHRA. The FDA is clearly not buying it as otherwise NWBO would have filed in the U.S. which